What is the management of myocardial infarction (MI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Myocardial Infarction (MI)

The management of myocardial infarction requires immediate reperfusion therapy for patients with ST-segment elevation or new left bundle-branch block, along with comprehensive pharmacological therapy including aspirin, P2Y12 inhibitors, beta-blockers, and ACE inhibitors to reduce mortality and improve outcomes. 1

Initial Emergency Department Management

  • Administer oxygen via nasal prongs immediately upon arrival 2, 3
  • Give sublingual nitroglycerin unless systolic blood pressure is <90 mmHg or heart rate is <50 or >100 beats per minute 2, 3
  • Administer adequate analgesia (morphine sulfate or meperidine) for pain control 2, 4
  • Give aspirin 160-325 mg orally immediately 2, 1, 5
  • Perform a 12-lead ECG within 10 minutes of arrival to assess for ST-segment elevation or new LBBB 2, 3
  • Establish continuous cardiac monitoring with emergency resuscitation equipment readily available 3

Reperfusion Strategy

  • Evaluate for immediate reperfusion therapy if presenting within 12 hours of symptom onset 2, 3, 1
  • Primary PCI is the preferred reperfusion strategy when it can be performed within 90 minutes by skilled personnel with access to emergency CABG surgery 2, 1, 6
  • If primary PCI cannot be performed in a timely manner, administer fibrinolytic therapy within 12 hours of symptom onset 2, 1
  • The greatest benefit from thrombolysis occurs when administered within the first hour of symptom onset (35 lives saved per 1000 patients treated) 2, 3
  • For patients receiving alteplase (tPA), continue intravenous heparin for an additional 48 hours 2

Pharmacological Management in First 24 Hours

  • Begin intravenous nitroglycerin for 24-48 hours if no hypotension, bradycardia, or excessive tachycardia is present 2, 3
  • Administer early intravenous beta-blocker therapy followed by oral therapy if no contraindications exist 2, 1, 7
  • For metoprolol, administer three bolus injections of 5 mg intravenously at approximately 2-minute intervals, followed by 50 mg orally every 6 hours, starting 15 minutes after the last IV dose 7
  • Consider dual antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor (such as prasugrel) for patients undergoing PCI 1, 8
  • For prasugrel, administer a 60 mg oral loading dose followed by 10 mg daily (consider 5 mg daily for patients <60 kg) 8
  • Consider ACE inhibitors, particularly for patients with anterior MI or left ventricular dysfunction 3, 1

Monitoring and Management After First 24 Hours

  • Continue aspirin 160-325 mg daily indefinitely 2, 1
  • Continue beta-blocker therapy for at least 6 weeks 2, 3
  • Maintain intravenous nitroglycerin for 24-48 hours 2, 3
  • Administer magnesium sulfate as needed to replete magnesium deficits for 24 hours 2, 3
  • Monitor for and promptly manage complications such as recurrent chest pain, heart failure, arrhythmias, and mechanical complications 2

Management of Complications

  • For recurrent chest pain due to pericarditis, administer high-dose aspirin (650 mg every 4-6 hours) 2
  • For recurrent chest pain due to ischemia, treat with intravenous nitroglycerin, analgesics, and antithrombotic medications (aspirin, heparin) 2
  • For heart failure, administer diuretics (usually intravenous furosemide) and afterload-reducing agents 2, 1
  • For cardiogenic shock, consider intra-aortic balloon counterpulsation and emergency coronary angiography followed by PCI or CABG 2, 1
  • For right ventricular infarction with dysfunction, provide vigorous intravascular volume expansion (using normal saline) and inotropic agents if hypotension persists 2

Pre-Discharge Evaluation

  • Perform echocardiography during hospital stay to assess ventricular function and detect complications 1
  • Before discharge or shortly thereafter, conduct exercise testing (submaximal at 4-7 days or symptom-limited at 10-14 days) 2, 1
  • Exercise testing helps assess functional capacity, evaluate efficacy of medical regimen, and stratify risk for subsequent cardiac events 2

Long-Term Management

  • Continue aspirin, beta-blockers, and ACE inhibitors indefinitely 2, 1
  • Encourage smoking cessation with appropriate support 2, 1
  • Recommend participation in a formal cardiac rehabilitation program 2, 1
  • Advise patients to achieve ideal weight and follow a diet low in saturated fat and cholesterol 2, 1
  • Target LDL cholesterol <100 mg/dL with appropriate diet and medication 2
  • Encourage regular exercise (at least 20 minutes of brisk walking three times weekly) 2, 1

Common Pitfalls and Caveats

  • Delaying reperfusion therapy beyond the golden first hour significantly reduces its effectiveness 3, 9
  • Using oral nitrates instead of intravenous nitroglycerin in the acute phase prevents proper dose titration 2, 3
  • Calcium channel blockers have not been shown to reduce mortality and may be harmful in certain patients 2
  • Prasugrel is contraindicated in patients with a history of TIA or stroke and should be used cautiously in patients ≥75 years of age due to increased bleeding risk 8
  • Avoid prophylactic antiarrhythmic agents in the first 24 hours 3

References

Guideline

Management of Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Anterior Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of acute myocardial infarction: a cardiologist's perspective.

International anesthesiology clinics, 1992

Research

Myocardial Infarction: Symptoms and Treatments.

Cell biochemistry and biophysics, 2015

Research

Myocardial ischemia reperfusion injury: from basic science to clinical bedside.

Seminars in cardiothoracic and vascular anesthesia, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.